Home » Headlines » Currently Reading:

Morning Headlines 4/26/22

April 25, 2022 Headlines No Comments

UnitedHealth agrees to sell Change Healthcare’s ClaimsXten business for $2.2bn

UnitedHealth has agreed to sell Change Healthcare’s ClaimsXten claims payment and editing software business to TPG Capital for $2.2 billion, provided its acquisition of Change is finalized.

Ann Arbor’s Fifth Eye Partners with Texas Health Care Analytics Firm

AirStrip invests in clinical analytics company Fifth Eye as part of a collaboration that will include integration of Fifth Eye’s AHI System with AirStrip’s One platform for inpatient surveillance.

LifePoint Health to Lead Investment in Specialist TeleMed

Specialist TeleMed secures an undisclosed amount of funding from LifePoint Health (TN).

Fathom Secures Investment From Vituity’s Inflect Health

Medical coding automation vendor Fathom secures funding from Inflect Health, the innovation arm of Vituity, a provider group based in Emeryville, CA.



HIStalk Featured Sponsors

     

Text Ads


RECENT COMMENTS

  1. "A valid concern..." Oh please. Everyone picks the software they like and the origin of that software is an afterthought.…

  2. I don't disagree with you completely, but to take the counterpoint: there is plenty of precedent for saying "this *entire…

  3. Teens will certainly find a way to use their social media apps of choice. I'm not in favor of the…

  4. I've been in this business a long time. Choosing the "right" technology product is fraught, especially when it comes to…

  5. EHRMusing - You make a lot of accurate statements about key factors in the selection process but the comment about…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.